全球更年期治疗市场：依治疗类型、给药途径、剂型、适应症、通路及地区

2023年全球更年期治疗市场价值为153.3亿美元，预计2024年至2031年复合年增长率为5.9%，到2031年达到243.3亿美元。

图 1. 2023 年按地区分類的更年期治疗的全球市场占有率(%)

更年期是一种自然的生物过程，通常发生在女性 45 岁至 55 岁之间。更年期标誌着女性生育期的结束和生育后生活的过渡。更年期最常见的征兆和症状包括月经、潮热、盗汗、阴道干燥、情绪变化和睡眠问题。随着更年期的进展，女性的雌激素水平急剧下降，如果不加以控制，可能会导致长期的健康风险。因此，管理这种过渡状况是许多女性的首要任务。全球更年期治疗市场为患有更年期症状的女性提供了多种治疗选择。

市场动态：

由于生活方式的改变和健康意识的提高，女性更年期盛行率的增加是推动全球更年期治疗市场成长的关键因素。根据大量研究，大约四分之一的 40 岁至 60 岁女性表示至少经历过一种与更年期相关的问题症状。久坐工作和缺乏运动也会增加过早闭经和过早闭经的风险。此外，大型製药企业核准和推出新产品正在扩大解决更年期血管舒缩症状的治疗选择。然而，与荷尔蒙补充疗法相关的副作用和替代治疗方案的可用性仍然在一定程度上限制了市场潜力。此外，新兴国家对治疗的认知度较低也是市场相关人员面临的挑战。儘管如此，亚太地区更年期护理的技术进步和医疗旅游的扩张预计将在未来几年为相关人员提供利润丰厚的机会。

本研究的主要特点

• 本报告对全球更年期治疗市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
• 它还说明了各个细分市场的潜在收益成长机会，并为该市场提供了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球更年期治疗市场的主要企业。
• 该报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球更年期治疗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于分析全球更年期治疗市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

• 市场动态
  • 新产品发布
  • 老年人口增加
  • 透过资金和投资提供财政支持
• 影响分析
• 主要亮点
• 市场趋势
• PEST分析
• 监管场景
• 合併、收购和合作
• 主要提供服务
• 治疗费用分析
• 识别顶级市场参与者
• 政府措施和投资
• 品牌映射和价格分析
• 按国家/地区分類的医疗保健支出

第四章全球更年期治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球更年期治疗市场，依治疗类型，2019-2031

• 荷尔蒙疗法
• 雌激素类药物
• 黄体素药物
• 组合药物（雌激素与黄体素、雌激素与其他药物）
• 非荷尔蒙疗法
• 神经激肽 3 (NK3)
• 受体拮抗
• 选择性血清素
• 再回收抑制剂（SSRIs）
• 其他的

第六章全球更年期治疗市场，依给药途径，2019-2031

• 口服
• 外用
• 胃肠外的
• 阴道
• 其他的

第七章全球更年期治疗市场，按剂型，2019-2031

• 锭剂
• 奶油
• 修补
• 子宫托
• 注射
• 其他的

第八章全球更年期治疗市场（按适应症），2019-2031

• 闭经
• 停经
• 停经后

第9章全球更年期治疗市场，依通路，2019-2031

• 医院药房
• 零售药房
• 网路药房
• 专卖店
• 其他的

第10章全球更年期治疗市场，按地区，2019-2031

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第十一章竞争格局

• 公司简介
  • Novartis AG
  • Pfizer Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Novo Nordisk A/S
  • illendo Therapeutics, Inc.
  • Mithra Pharmaceuticals
  • Merck &Co., Inc
  • Cipla Inc.
  • Abbott
  • Viatris Inc.
  • Organon
  • SnapNurse
  • Glenmark Pharmaceuticals Limited
  • Procter &Gamble
  • Duchesnay USA.
  • TherapeuticsMD, Inc.
  • Avion Pharmaceuticals
  • KWS
  • PharmaCare Europe Ltd.
  • Amneal Pharmaceuticals LLC.

第12章 章节

• 参考
• 调查方法
• 关于出版商

The global menopause treatment market was valued US$ 15.33 Bn in 2023 and is expected to reach US$ 24.33 Bn by 2031 growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Figure 1. Global Menopause Treatment Market Share (%), By Region, 2023

Menopause is a natural biological process that usually occurs between the ages of 45 to 55 years in women. It marks the end of a woman's reproductive years and the transition into her post-reproductive life. Some of the most common signs and symptoms of menopause include irregular menstrual periods, hot flashes, night sweats, vaginal dryness, mood changes, and difficulty sleeping. As menopause progresses, a woman's estrogen levels drop dramatically, which could lead to several long-term health risks if left untreated. Therefore, managing symptoms during this transitional phase has become a priority for many women. The global menopause treatment market offers a variety of treatment options for women suffering from menopause symptoms.

Market Dynamics:

The rising prevalence of menopause issues among women owing to changing lifestyle patterns and growing health awareness levels is a key factor driving the growth of global menopause treatment market. Numerous researches have shown that approximately one-fourth of women within the age group of 40 to 60 years report experiencing at least one problematic symptom associated with menopause. There is also the emergence of sedentary jobs and a lack of physical activity, which has escalated the risks of premature or early menopause. Additionally, new product approvals and launches by leading pharmaceutical players are expanding the treatment choices for addressing vasomotor symptoms during menopause. However, side effects associated with hormone replacement therapy and the availability of alternative treatment options still limit the market potential to a certain extent. Moreover, a lack of awareness about treatment in developing nations poses a challenge to market players. Nonetheless, technological advancements in menopausal care and growing medical tourism in the Asia Pacific region are expected to unlock lucrative opportunities for stakeholders in coming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global menopause treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global menopause treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novo Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck & Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organon, SnapNurse, Glenmark Pharmaceuticals Limited, Procter & Gamble, Duchesnay USA., TherapeuticsMD, Inc., Avion Pharmaceuticals, KWS, PharmaCare Europe Ltd., Amneal Pharmaceuticals LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global menopause treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menopause treatment market

Detailed Segmentation:

• Global Menopause Treatment Market, By Treatment Type
  • Hormone Therapy
  • Estrogen-based Drugs
  • Progestin-based Drugs
  • Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
  • Non-hormonal Therapy
  • Neurokinin 3 (NK3)
  • Receptor Antagonist
  • Selective Serotonin
  • Reuptake Inhibitor (SSRI)
  • Others
  • Others
• Global Menopause Treatment Market, By Route of Administration
  • Oral
  • Topical
  • Parenteral
  • Vaginal
  • Others
• Global Menopause Treatment Market, By Form
  • Tablets
  • Creams
  • Patches
  • Pessaries
  • Injections
  • Others
• Global Menopause Treatment Market, By Indication
  • Perimenopause
  • Menopause
  • Postmenopause
• Global Menopause Treatment Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Stores
  • Others
• Global Menopause Treatment Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Top Companies in the Global Menopause Treatment Market:
  • Novartis AG
  • Pfizer Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Novo Nordisk A/S
  • illendo Therapeutics, Inc.
  • Mithra Pharmaceuticals
  • Merck & Co., Inc
  • Cipla Inc.
  • Abbott
  • Viatris Inc.
  • Organon
  • Glenmark Pharmaceuticals Limited
  • Procter & Gamble
  • Duchesnay USA.
  • TherapeuticsMD, Inc.
  • Avion Pharmaceuticals
  • KWS
  • PharmaCare Europe Ltd.
  • Amneal Pharmaceuticals LLC.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Treatment Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Form
  • Market Snippet, By Indication
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • New Product Launches
  • Rising Geriatric Population
  • Financial Support Through Funding And Investments
• Impact Analysis
• Key Highlights
• Market Trends
• PEST Analysis
• Regulatory Scenario
• Mergers, Acquisitions, and Collaborations
• Key Services Offered
• Treatment cost Analysis
• Identification of Top Market Players
• Government Initiatives and Investments
• Brand Mapping & Pricing Analysis
• Healthcare Spending by Country

4. Global Menopause Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Menopause Treatment Market, By Treatment Type, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hormone Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Estrogen-based Drugs
• Progestin-based Drugs
• Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
• Non-hormonal Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Neurokinin 3 (NK3)
• Receptor Antagonist
• Selective Serotonin
• Reuptake Inhibitor (SSRI)
• Others
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Menopause Treatment Market, By Route of Administration, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Vaginal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Menopause Treatment Market, By Form, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Tablets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Creams
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Pessaries
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Injections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Menopause Treatment Market, By Indication, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Perimenopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Menopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Postmenopause
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Menopause Treatment Market, By Distribution Channel, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Specialty Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

10. Global Menopause Treatment Market, By Region, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region/Country, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region/Country, 2020 - 2031
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• North Africa
• Central Africa
• South Africa

11. Competitive Landscape

• Company Profile
  • Novartis AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Novo Nordisk A/S
  • illendo Therapeutics, Inc.
  • Mithra Pharmaceuticals
  • Merck & Co., Inc
  • Cipla Inc.
  • Abbott
  • Viatris Inc.
  • Organon
  • SnapNurse
  • Glenmark Pharmaceuticals Limited
  • Procter & Gamble
  • Duchesnay USA.
  • TherapeuticsMD, Inc.
  • Avion Pharmaceuticals
  • KWS
  • PharmaCare Europe Ltd.
  • Amneal Pharmaceuticals LLC.
• Analyst Views

12. Section

• References
• Research Methodology
• About us